GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 74 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,088,000 | +1253.2% | 631,303 | +726.3% | 0.01% | +600.0% |
| Q4 2020 | $1,115,000 | +2.8% | 76,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,085,000 | +5.5% | 76,400 | +9.3% | 0.00% | 0.0% |
| Q2 2020 | $1,028,000 | +196.3% | 69,900 | -17.0% | 0.00% | – |
| Q1 2020 | $347,000 | +10.5% | 84,200 | +28.9% | 0.00% | – |
| Q4 2019 | $314,000 | -20.7% | 65,300 | 0.0% | 0.00% | – |
| Q3 2019 | $396,000 | -6.6% | 65,300 | 0.0% | 0.00% | – |
| Q2 2019 | $424,000 | -0.9% | 65,300 | +8.3% | 0.00% | – |
| Q1 2019 | $428,000 | +57.9% | 60,300 | +8.1% | 0.00% | – |
| Q4 2018 | $271,000 | -33.9% | 55,800 | 0.0% | 0.00% | – |
| Q3 2018 | $410,000 | +15.2% | 55,800 | 0.0% | 0.00% | – |
| Q2 2018 | $356,000 | +32.8% | 55,800 | +13.2% | 0.00% | – |
| Q1 2018 | $268,000 | +30.1% | 49,300 | 0.0% | 0.00% | – |
| Q4 2017 | $206,000 | -56.6% | 49,300 | 0.0% | 0.00% | – |
| Q3 2017 | $475,000 | -24.4% | 49,300 | -7.2% | 0.00% | – |
| Q2 2017 | $628,000 | -7.8% | 53,100 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $681,000 | -0.9% | 53,100 | -5.3% | 0.00% | 0.0% |
| Q4 2016 | $687,000 | +3.8% | 56,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $662,000 | +35.7% | 56,100 | 0.0% | 0.00% | – |
| Q2 2016 | $488,000 | +71.8% | 56,100 | +4.3% | 0.00% | – |
| Q1 2016 | $284,000 | -35.0% | 53,800 | -4.4% | 0.00% | – |
| Q4 2015 | $437,000 | -1.4% | 56,300 | 0.0% | 0.00% | – |
| Q3 2015 | $443,000 | -13.1% | 56,300 | 0.0% | 0.00% | – |
| Q2 2015 | $510,000 | -32.5% | 56,300 | -3.3% | 0.00% | -100.0% |
| Q1 2015 | $755,000 | -4.7% | 58,200 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $792,000 | +51.7% | 58,200 | 0.0% | 0.00% | – |
| Q3 2014 | $522,000 | -33.7% | 58,200 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $787,000 | +120.4% | 58,200 | +62.0% | 0.00% | – |
| Q1 2014 | $357,000 | -25.3% | 35,923 | 0.0% | 0.00% | – |
| Q4 2013 | $478,000 | +67.7% | 35,923 | +53.4% | 0.00% | – |
| Q3 2013 | $285,000 | +14.5% | 23,423 | -2.7% | 0.00% | – |
| Q2 2013 | $249,000 | – | 24,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |